Delray Medical Center now uses the POLARx cryoablation system to treat patients diagnosed with paroxysmal atrial fibrillation, which is an irregular, rapid heartbeat.
During the cryoablation procedure, a balloon catheter delivers cryotherapy to the pulmonary vein, creating scar tissue to block irregular electrical signals. This new system, utilizing a special device that enables two balloon sizes in one catheter, allows physicians to address a wider range of pulmonary vein structures, and helps to achieve more complete tissue contact to better deliver treatment.
***
FloSpine and the Research Park at Florida Atlantic University have announced the successful implantation of the Ti-Largo 3D printed cervical cage, which is designed to complement the FDA-cleared Panama anterior cervical plate. This procedure is used for minimally invasive spine surgeries.
The cervical cage uses 3D printing technology, so it is a highly customizable, patient-specific implant and is printed from a high-grade titanium alloy that minimizes the risk of adverse reactions and offers long-term durability.
The cage also has a porous structure that facilitates bone ingrowth, which promotes fusion and long-term stability.
This implantation was conducted in September by Dr. John Afshar, a spinal surgeon at Palm Beach Neuroscience Institute. FloSpine developed the implant.
“The Ti-Largo cervical cage represents a major leap forward in cervical spine surgery. Its patient-specific design and 3D printing technology have the potential to revolutionize the way we approach these procedures, offering greater precision and improved outcomes for our patients,” he said.
***
Two Boca Raton companies were among the finalists for the GrowFL Florida Companies to Watch awards: HelixVM, a health care company, and PUR-FORM, a medical clinic.
Qualifying businesses must have between six and 150 employees and revenue between $750,000 and $100 million in 2022. The Orlando-based GrowFL organization supports Florida’s second-stage companies and their leaders.
Send health news to Christine Davis at cdavis9797@gmail.com.
Comments